Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial - Concepedia

Concepedia

Publication | Open Access

Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

DOI Full Paper Access

57

Citations

29

References

2018

Year

Toshihiko Doi, Satoru Iwasa, Kei Muro, Taroh Satoh, Shuichi Hironaka, Taito Esaki, Tomohiro Nishina, Hiroki Hara, Nozomu Machida, Yoshito Komatsu,

Abstract

Avelumab showed acceptable safety in Japanese patients with advanced solid tumors and clinical activity in patients with advanced gastric cancer/gastroesophageal junction cancer and disease progression after chemotherapy.

References

	Year	Citations

Page 1